首页 | 本学科首页   官方微博 | 高级检索  
     


Long-survivors of glioblatoma treated with boron neutron capture therapy (BNCT)
Authors:T. Kageji  Y. Mizobuchi  S. Nagahiro  Y. Nakagawa  H. Kumada
Affiliation:aDepartment of Neurosurgery, Kagawa National Children's Hospital, Kagawa, Japan;bDepartment of Neurosurgery, The University of Tokushima, Tokushima, Japan;cDepartment of Radiation Oncology, Graduate School of Comprehensive Human Science, University of Tsukuba, Ibaragi, Japan
Abstract:The purpose of this study was to compare the radiation dose between long-survivors and non-long-survivors in patients with glioblatoma (GBM) treated with boron neutron capture therapy (BNCT). Among 23 GBM patients treated with BNCT, there were five patients who survived more than three years after diagnosis. The physical and weighted dose of the minimum gross tumor volume (GTV) of long-survivors was much higher than that of non-long survivors with significant statistical differences.
Keywords:BNCT   Glioblatoma   Survival
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号